NUBLEXA – BAYER PHARMACEUTICALS – REGORAFENIB TABLETS

WHAT IS NUBLEXA 40 MG?

Enquire now for  NUBLEXA 40 mg online as it contains the active ingredient named Regorafenib. This drug is used to target cancerous diseases. The main method this drug used to function is by blocking cancer cells proteins that boost the growth of such cells, thus it may also be referred as cancer growth blocker. FDA in the year 2017 expanded the indications of NUBLEXA 40Mg Tablet to include hepatocellular carcinoma. This wonder drug has also been included as a potential cure agent for multiple types of tumours. These tablets are administered to treat and delay the growth of the tumour in patients with gastrointestinal stromal tumours. This medication has been manufactured by Cadila Pharmaceutical Ltd. is a multinational research based pharmaceutical company in India with an experience of more than 5 decades in providing high quality affordable products.

WHAT IS NUBLEXA 40 MG?

Regorafenib tablets are used to target cancerous diseases. The main method this drug used to function is by blocking cancer cells proteins that boost the growth of such cells, thus it may also be referred as cancer growth blocker.

NUBLEXA USES:

Enquire now for NUBLEXA 40 mg online from the best supplier, Galaxysuperspeciality and get best price for NUBLEXA tablets as this medication is used for treating the patients with colorectal cancer that has spread to other areas of the body. It is also used for the treatment of patients with a type of stomach, bowel, or oesophagus cancer referred to as gastrointestinal stromal tumours (GIST).

INDICATIONS OF NUBLEXA 40 MG:

Regorafenib (NUBLEXA) contains the active ingredient named Regorafenib and it is indicated for treating patients with metastatic colorectal cancer and it is also indicated for the treatment of patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumour.

NUBLEXA 40 MG COMMON SIDE EFFECTS:

Taking NUBLEXA 40 MG may lead to side effects that are very alarming in some cases when taken without professional guidance, thus seeking medical help before ordering this medicine is a must. Some of the severe resultant side effects are:

• Severe liver toxicity
• Bleeding
• Skin-peeling
• Blood pressure

While some of the common side effects of NUBLEXA 40 MG are:

• Weakness
• Fatigue
• Loss of appetite
• Diarrhoea
• Weight loss
• Pain or sores in the mouth/throat
• Changes in taste
• Dry mouth
• Hair loss
• Voice changes
• Muscle stiffness
• Infections and some more

If you experience any of these effects or you feel they persist or worsen, inform your doctor or medical healthcare provider immediately. Also the list is does not include all the side effects, make sure to consult your doctor before you Enquire this medicine online from the leading supplier, Galaxysuperspeciality that provides best price for NUBLEXA tablets. Keep in mind to inform your doctor if you experience anything that is not part of the list mentioned above.

DOSAGE INSTRUCTIONS:

The recommended dose instructions are mentioned below, but before ordering this medication online consult your doctor as this is a prescription medicine:

• The drug usually comes in tablet form
• This tablet should be taken once a day as per the doctor’s advice
• It is ideally taken at the same time every day
• It has been seen that it is usually prescribed to be taken every day for 3 weeks and then a gap of 1 week is given before restarting the dosage.
• Do not crush or chew the tablets- swallow the tablets as a whole with water.

TABLET FORM:

The NUBLEXA tablets manufactured by Cadila Pharmaceutical Ltd. come in a sealed plastic bottle with 28 tablets; each tablet contains the active salt Regorafenib with the strength of 40 mg.

TREATMENT DURATION OF ABIRAPRO 250MG:

The duration of the tablet depends upon the condition of the patient. Therefore, it must be consumed as prescribed.

CONTRADICTIONS AND PRECAUTIONS:

NUBLEXA tablets are known to cause some harmful effects when contradicted, such as:

• Severe and sometimes fatal hepatotoxicity has been reported with use of Regorafenib
• Fatal bleeding has been reported with the use of these tablets including GI bleeding and bleeding from the respiratory and genitourinary tracts (Permanently discontinue Regorafenib therapy in patients who develop severe or life-threatening bleeding)
• Skin toxicity has been reported frequently including palmar-plantar erythrodysesthesia (hand and foot syndrome) rash, and toxic epidermal necrolysis (TEN).
• Hypertension including hypertensive crisis has been reported in patients with pre-existing hypertension. Do not start Regorafenib therapy until blood pressure is adequately controlled. Monitor blood pressure weekly for the first 6 weeks of therapy.
• Myocardial ischemia and infarction has been seen with use of Regorafenib use. Hold therapy in patients who develop new or acute onset cardiac disease (ischemia) or acute myocardial infarction.
• GI perforation or fistula has been reported rarely with Regorafenib use.
• Impaired wound healing may occur with vascular endothelial growth factor receptor inhibitors, such as Regorafenib. Thus, a temporary suspension of therapy is recommended at least 2 weeks before elective surgery. Resume Regorafenib therapy based on clinical judgement of adequate wound healing. Discontinue therapy in patients who develop wound dehiscence.
• Pregnancy should be avoided by females of reproductive potential during use of Regorafenib treatment and for at least 2 months after the last dose. Although there are no adequately controlled studies in pregnant animals or humans, Regorafenib may cause fetal harm when administered during pregnancy.

STORAGE INSTRUCTIONS:

• Keep this medication away from the reach of children.
• Do not use this medication after it has crossed the expiry date
• Store the medicine below Room Temperature at 25°C.
• Protected the medicine from direct sunlight and heat.
• Always keep the tablets tightly closed in its original bottle as it contains a special drying agent (called a desiccant) to keep your medicine dry. Remove the drying agent to get tablets from the bottle